209 related articles for article (PubMed ID: 27862904)
1. Baseline blood pressure control in Hispanics: characteristics of Hispanics in the Systolic Blood Pressure Intervention Trial.
Rodriguez CJ; Still CH; Garcia KR; Wagenknecht L; White S; Bates JT; Del Cid MV; Lioudis M; Lopez Barrera N; Moreyra A; Punzi H; Ringer RJ; Cushman WC; Contreras G; Servilla K; Rocco M;
J Clin Hypertens (Greenwich); 2017 Feb; 19(2):116-125. PubMed ID: 27862904
[TBL] [Abstract][Full Text] [Related]
2. Blood pressure control in Hispanics in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
Margolis KL; Piller LB; Ford CE; Henriquez MA; Cushman WC; Einhorn PT; Colon PJ; Vidt DG; Christian R; Wong ND; Wright JT; Goff DC;
Hypertension; 2007 Nov; 50(5):854-61. PubMed ID: 17846352
[TBL] [Abstract][Full Text] [Related]
3. Influence of baseline systolic blood pressure on the relationship between intensive blood pressure control and cardiovascular outcomes in the Systolic Blood Pressure Intervention Trial (SPRINT).
Sun X; Guo Y; Nie Z; Cheng J; Zhou H; Zhong X; Zhang S; Du Z; Zhuang X; Liao X
Clin Res Cardiol; 2019 Mar; 108(3):273-281. PubMed ID: 30167807
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Therapeutic Inertia and Race and Ethnicity in the Systolic Blood Pressure Intervention Trial: A Secondary Analysis of a Randomized Clinical Trial.
Zheutlin AR; Mondesir FL; Derington CG; King JB; Zhang C; Cohen JB; Berlowitz DR; Anstey DE; Cushman WC; Greene TH; Ogedegbe O; Bress AP
JAMA Netw Open; 2022 Jan; 5(1):e2143001. PubMed ID: 35006243
[TBL] [Abstract][Full Text] [Related]
5. Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical Trial.
Still CH; Rodriguez CJ; Wright JT; Craven TE; Bress AP; Chertow GM; Whelton PK; Whittle JC; Freedman BI; Johnson KC; Foy CG; He J; Kostis JB; Lash JP; Pedley CF; Pisoni R; Powell JR; Wall BM;
Am J Hypertens; 2017 Dec; 31(1):97-107. PubMed ID: 28985268
[TBL] [Abstract][Full Text] [Related]
6. Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control.
Beddhu S; Chertow GM; Cheung AK; Cushman WC; Rahman M; Greene T; Wei G; Campbell RC; Conroy M; Freedman BI; Haley W; Horwitz E; Kitzman D; Lash J; Papademetriou V; Pisoni R; Riessen E; Rosendorff C; Watnick SG; Whittle J; Whelton PK;
Circulation; 2018 Jan; 137(2):134-143. PubMed ID: 29021322
[TBL] [Abstract][Full Text] [Related]
7. Cognitive Associates of Current and More Intensive Control of Hypertension: Findings From the Hispanic Community Health Study/Study of Latinos.
Lamar M; Wu D; Durazo-Arvizu RA; Brickman AM; Gonzalez HM; Tarraf W; Daviglus ML
Am J Hypertens; 2017 Jun; 30(6):624-631. PubMed ID: 28402388
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Long-term Benefit of Intensive Blood Pressure Control on Residual Life Span: Secondary Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
Vaduganathan M; Claggett BL; Juraschek SP; Solomon SD
JAMA Cardiol; 2020 May; 5(5):576-581. PubMed ID: 32101262
[TBL] [Abstract][Full Text] [Related]
9. Orthostatic changes in systolic blood pressure among SPRINT participants at baseline.
Townsend RR; Chang TI; Cohen DL; Cushman WC; Evans GW; Glasser SP; Haley WE; Olney C; Oparil S; Del Pinto R; Pisoni R; Taylor AA; Umanath K; Wright JT; Yeboah J;
J Am Soc Hypertens; 2016 Nov; 10(11):847-856. PubMed ID: 27665708
[TBL] [Abstract][Full Text] [Related]
10. Personalizing the Intensity of Blood Pressure Control: Modeling the Heterogeneity of Risks and Benefits From SPRINT (Systolic Blood Pressure Intervention Trial).
Patel KK; Arnold SV; Chan PS; Tang Y; Pokharel Y; Jones PG; Spertus JA
Circ Cardiovasc Qual Outcomes; 2017 Apr; 10(4):. PubMed ID: 28373269
[TBL] [Abstract][Full Text] [Related]
11. Baseline characteristics of African Americans in the Systolic Blood Pressure Intervention Trial.
Still CH; Craven TE; Freedman BI; Van Buren PN; Sink KM; Killeen AA; Bates JT; Bee A; Contreras G; Oparil S; Pedley CM; Wall BM; White S; Woods DM; Rodriguez CJ; Wright JT;
J Am Soc Hypertens; 2015 Sep; 9(9):670-9. PubMed ID: 26320890
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing blood pressure response to trandolapril add-on therapy in patients taking verapamil SR (from the International Verapamil SR/Trandolapril [INVEST] Study).
Brunner M; Cooper-DeHoff RM; Gong Y; Karnes JH; Langaee TY; Pepine CJ; Johnson JA;
Am J Cardiol; 2007 Jun; 99(11):1549-54. PubMed ID: 17531579
[TBL] [Abstract][Full Text] [Related]
13. Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey).
Bress AP; Kramer H; Khatib R; Beddhu S; Cheung AK; Hess R; Bansal VK; Cao G; Yee J; Moran AE; Durazo-Arvizu R; Muntner P; Cooper RS
Circulation; 2017 Apr; 135(17):1617-1628. PubMed ID: 28193605
[TBL] [Abstract][Full Text] [Related]
14. Blood pressure and hypertension in an American colony (Puerto Rico) and on the USA mainland compared, 1886-1930.
Godoy R; Goodman E; Gravlee C; Levins R; Seyfried C; Caram M; Jha N
Econ Hum Biol; 2007 Jul; 5(2):255-79. PubMed ID: 17420157
[TBL] [Abstract][Full Text] [Related]
15. Impact of Intensive Versus Standard Blood Pressure Management by Tertiles of Blood Pressure in SPRINT (Systolic Blood Pressure Intervention Trial).
Shapiro BP; Ambrosius WT; Blackshear JL; Cushman WC; Whelton PK; Oparil S; Beddhu S; Dwyer JP; Gren LH; Kostis WJ; Lioudis M; Pisoni R; Rosendorff C; Haley WE;
Hypertension; 2018 Jun; 71(6):1064-1074. PubMed ID: 29712745
[TBL] [Abstract][Full Text] [Related]
16. Generalizability of SPRINT Results to the U.S. Adult Population.
Bress AP; Tanner RM; Hess R; Colantonio LD; Shimbo D; Muntner P
J Am Coll Cardiol; 2016 Feb; 67(5):463-72. PubMed ID: 26562046
[TBL] [Abstract][Full Text] [Related]
17. Influence of Prediabetes on the Effects of Intensive Systolic Blood Pressure Control on Kidney Events.
Rathi N; Whelton PK; Chertow GM; Cushman WC; Cheung AK; Wei G; Boucher R; Kimmel PL; Bress AP; Kramer HJ; Al-Marji C; Greene T; Beddhu S
Am J Hypertens; 2019 Nov; 32(12):1170-1177. PubMed ID: 31257407
[TBL] [Abstract][Full Text] [Related]
18. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).
Soliman EZ; Ambrosius WT; Cushman WC; Zhang ZM; Bates JT; Neyra JA; Carson TY; Tamariz L; Ghazi L; Cho ME; Shapiro BP; He J; Fine LJ; Lewis CE;
Circulation; 2017 Aug; 136(5):440-450. PubMed ID: 28512184
[TBL] [Abstract][Full Text] [Related]
19. Incident Cardiovascular Disease Among Adults With Blood Pressure <140/90 mm Hg.
Tajeu GS; Booth JN; Colantonio LD; Gottesman RF; Howard G; Lackland DT; O'Brien EC; Oparil S; Ravenell J; Safford MM; Seals SR; Shimbo D; Shea S; Spruill TM; Tanner RM; Muntner P
Circulation; 2017 Aug; 136(9):798-812. PubMed ID: 28634217
[TBL] [Abstract][Full Text] [Related]
20. Quality of Care for White and Hispanic Medicare Advantage Enrollees in the United States and Puerto Rico.
Rivera-Hernandez M; Leyva B; Keohane LM; Trivedi AN
JAMA Intern Med; 2016 Jun; 176(6):787-94. PubMed ID: 27111865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
